تجاوز إلى المحتوى الرئيسي

بحث

عنوان الدراسة داعم الدراسة حالة الدراسة دواء الدراسة مرحلة الدراسة رقم بروتوكول الدراسة موقع الدراسة
The Influence of a rapid relief of gastro esophageal reflux disease (GERD) symptoms on the quality of life and patient satisfaction after initiating treatment with a Proton Pump Inhibitor. Sanofi Ongoing N/A 4 DRIEG_L_05705 University District Hospital (Jeddah)
International Diabetes Management Practices Study (Wave 5) Sanofi Ongoing N/A 4 DIREG_R_05941 King Fahad Hospital (Jeddah)
An observational study to monitor the efficacy and tolerability of levofloxacin 250 mg OD for treatment of simple lower UTI in Saudi Arabia Sanofi Ongoing Levofloxacin 4 LEVOF_L_05172 Erfan & Bagedo General Hospital (Jeddah)
A randomized, double-blind, placebo-controlled phase II study to investigate the efficacy and safety of riociguat (0.5 mg, 1.0 mg, 1.5 mg, 2.0 mg and 2.5 mg TID) in patients with symptomatic pulmonary hypertension associated with idiopathic interstitial pneumonias (IIP). Bayer Completed Riociguat 2 BAY 63-2521 / 13605 King Fahad Medical City (Riyadh), King Khalid University Hospital (Riyadh)
Tracking Biologics Along the Silk Road Janssen-Cilag International NV Ongoing Infliximab / Golimumab / Ustekinumab 4 C0168ARA40 King Khalid University Hospital (Riyadh)
The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma orOcular Hypertension. Allergan Ongoing Bimatoprost SR 3 192024-092 King Khaled Eye Specialist Hospital (Riyadh), King Abdullah Medical City (Makkah)
Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers, An International, Multicenter, Double Blind, Randomized Placebo Controlled Phase 3 trial (ICR-02/ASCOLT) King Fahad Medical City Ongoing Aspirin 3 ICR-02/ASCOLT King Fahad Medical City (Riyadh)
Efficacy and Safety Assessment of NIlotinib in Chronic Myeloid Leukemia (CML) Patients with Suboptimal Response on Imatinib Therapy (NISRI) KAIMRC Ongoing NILOTINIB 4 RC12/052/R King Abdulaziz Medical City NG (Riyadh), King Fahad Specialist Hospital (Dammam)
Middle East Observational Study in Metastatic Soft Tissue Sarcoma: An epidemiological study on the treatment patterns Novartis Ongoing N/A 4 VEG201319 King Faisal Specialist Hospital and Research Center (Riyadh)
A study of the factors predicting radiation exposure to contacts of Saudi patients treated with radioactive iodine (I 131): A preliminary study for patients’ criteria selection for possible high dose I131 therapy on out-patient basis in the future King Abdulaziz City for Science and Technology (KACST) Completed 131 Iodine 4 (version#1) dated 10-Apr-14 King Abdullah Medical City (Makkah)
عرض 441 - 450 من 514